PEOPLE - Mosaic Technologies (US) makes appointment:
This article was originally published in Clinica
Mosaic Technologies, a US developer of products for the genomics research and gene-based clinical diagnostic markets, has appointed Cytyc president and CEO Patrick Sullivan to its board.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.